Key facts
- It has raised $9.6M; the latest was Accelerator/Incubator in May 2024.
- Notable investors include MassChallenge, MedTech Innovator, IP2 Launchpad, Alon MedTech Ventures, Dan Suesskind — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Butterfly Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Butterfly Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Butterfly Medical
Developer of an implantable medical device designed to assist in the treatment of Benign Prostatic Hyperplasia (BPH). The company's device is non-surgical, reversible, local anesthetic-based and can be used for prostate tissue removal and dilation of the urethra, enabling doctors with a minimally invasive alternative to traditional surgical interventions.
- Sector
- Healthcare
- HQ
- Yokneam, Israel
- Founded
- 2014
- Employees
- 20
- Website
- butterfly-medical.com/
- Ownership
- Privately Held (backing)
Butterfly Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Butterfly Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Butterfly Medical in its N-PORT filings yet. We sweep new filings monthly.